Fatigue in amyotrophic lateral sclerosis and correlated factors
Authors:
- Mariana Asmar AlencarMAMariana Asmar Alencar
- Bruna Laura SoaresBSBruna Laura Soares
- Marcela Ferreira de Andrade RangelMRMarcela Ferreira de Andrade Rangel
- Juliana Silva AbdoJAJuliana Silva Abdo
- Rayane Alves Pereira de AlmeidaRARayane Alves Pereira de Almeida
- Caroline Martins de AraújoCACaroline Martins de Araújo
- Leonardo Cruz de SouzaLSLeonardo Cruz de Souza
- Gisele de Cássia GomesGGGisele de Cássia Gomes
Open Access
- 1 October 2022
- journal article
- research article
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 80 (10) , 1045-1051
Abstract
Background Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that leads to muscle weakness and paralysis. Fatigue is a disabling symptom, frequently reported in ALS, but remains under-investigated in this population. Thus, an accurate investigation of this symptom and possible associated factors in this clinical condition is needed to assist in the establishment of an adequate treatment approach. Objective To investigate the presence of fatigue in individuals with ALS and possible factors correlated with this symptom. Methods Sixty-five individuals with sporadic ALS participated in the present study. Demographic, clinical, and functional aspects were investigated. Evaluations involved the Fatigue Severity Scale (FSS), ALS Functional Scale (ALSRFS-R), and Quality of Life (QoL) questionnaire (ALSAQ-40). Descriptive and correlation analyses were performed with SPSS statistical program for Windows version 19.0 (IBM Corp., Armonk, NY, USA). Results Among the 65 individuals evaluated, 44.6% (n = 29) presented fatigue based on the FSS. The mean fatigue intensity was 5.4 ± 1.2 and only 10.4% used a specific medication for fatigue. Differences between the groups with and without fatigue were found regarding sex (p = 0.049), pain intensity (p = 0.026), functioning (p = 0.004), disease severity (p = 0.029), and QoL (p = 0.000). Fatigue was correlated with pain intensity (r = 0.425; p = 0.001), muscle strength (r = - 0.356; p = 0.004), functioning (r = - 0.363; p = 0.003), and QoL (r = 0.481; p = 0.000). No correlations were found with age, time since diagnosis, cramps, or other mobility parameters. Conclusions Fatigue is a common symptom among individuals with ALS and may be present in all stages of the disease. This symptom was correlated with worse functioning, poorer QoL, greater pain intensity, disease severity, muscle weakness, and the female sex in individuals with ALS.Keywords
This publication has 25 references indexed in Scilit:
- The impact of fatigue and psychosocial variables on quality of life for patients with motor neuron diseaseAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2013
- Development of a patient reported outcome measure for fatigue in motor neurone disease: the Neurological Fatigue Index (NFI-MND)Health and Quality of Life Outcomes, 2011
- PND66 Cross-Cultural Adaptation and Validation of the Brazilian Version of the Fatigue Severity Scale (FSS)Value in Health, 2011
- Clinical diagnosis and management of amyotrophic lateral sclerosisNature Reviews Neurology, 2011
- Prevalence of fatigue and depression in ALS patients and change over timeJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Fatigue in Amyotrophic Lateral SclerosisPhysical Medicine and Rehabilitation Clinics of North America, 2008
- Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsyJournal of Rehabilitation Medicine, 2008
- Fatigue in amyotrophic lateral sclerosis: Frequency and associated factorsAmyotrophic Lateral Sclerosis, 2008
- Modafinil to treat fatigue in amyotrophic lateral sclerosis: An open label pilot studyAmerican Journal of Hospice and Palliative Medicine®, 2005
- The epidemiology of fatigue: more questions than answers.Journal of Epidemiology and Community Health, 1992